Warby Parker (WRBY) Net Income towards Common Stockholders (2020 - 2026)

Warby Parker (WRBY) reported Net Income towards Common Stockholders of $3.2 million for Q1 2026, down 8.5% on a YoY basis from $3.5 million in Q1 2025, and up 153.37% quarter-over-quarter from -$6.0 million in Q4 2025.

Warby Parker (WRBY) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Warby Parker has reported Net Income towards Common Stockholders for 7 years, with the latest figure at $3.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 8.5% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 109.45% YoY), and the FY2025 full-year result was $1.6 million, up 108.05% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at $3.2 million, up from -$6.0 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $5.9 million in Q3 2025, with the low at -$34.1 million in Q1 2022.
  • Historically, Net Income towards Common Stockholders has averaged -$11.1 million across 5 years, with a median of -$6.9 million in 2024.
  • Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 2030.65% — and 2025, when it soared 244.25%.
  • Warby Parker's Net Income towards Common Stockholders stood at -$20.3 million in 2022, then climbed by 5.95% to -$19.0 million in 2023, then jumped by 63.89% to -$6.9 million in 2024, then grew by 13.44% to -$6.0 million in 2025, then jumped by 153.37% to $3.2 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $3.2 million (Q1 2026), -$6.0 million (Q4 2025), and $5.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -274.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 239.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 398.73 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 135.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 13.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -77.90 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 112.77 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 2.00 Mn
10 Warby Parker 3.11 Bn 2.82 Bn 131.04 Mn 3.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.18 Mn
Dec 31, 2025 -5.95 Mn
Sep 30, 2025 5.87 Mn
Jun 30, 2025 -1.75 Mn
Mar 31, 2025 3.47 Mn
Dec 31, 2024 -6.88 Mn
Sep 30, 2024 -4.07 Mn
Jun 30, 2024 -6.76 Mn
Mar 31, 2024 -2.68 Mn
Dec 31, 2023 -19.05 Mn
Sep 30, 2023 -17.41 Mn
Jun 30, 2023 -15.93 Mn
Mar 31, 2023 -10.81 Mn
Dec 31, 2022 -20.25 Mn
Sep 30, 2022 -23.84 Mn
Jun 30, 2022 -32.17 Mn
Mar 31, 2022 -34.13 Mn
Dec 31, 2021 -45.90 Mn
Sep 30, 2021 -91.07 Mn
Jun 30, 2021 -18.83 Mn